Add to ORKGTiming alone doesn't influence the drug's efficacy in preventing postpartum bleeding (strength of recommendation: B, randomized controlled trial [RCT] and prospective cohort studies)
BACKGROUND: Primary postpartum haemorrhage (PPH) is one of the leading causes of maternal morbidity ...
Background and Objectives: To determine and compare the effects of the timing of oxytocin administra...
Objective To compare the available evidence on intravenous oxytocin dosing regimens for the prevent...
BackgroundThere is no consensus on the best timing for prophylactic oxytocin administration during c...
Background: PPH is the prime cause of maternal mortality worldwide. The incidence of PPH can be dras...
Background: Administration of the uterotonic drugs is one of the main components of the active manag...
Postpartum hemorrhage is a leading cause of maternal death worldwide. Rapid provision of uterotonics...
Introduction Maternity care providers administer oxytocin prophylactically to prevent postpartum hem...
Postpartum hemorrhage is a leading cause of maternal death worldwide. Rapid provision of uterotonics...
Objective The aim of the study is to investigate whether carbetocin prevents postpartum hemorrhage (...
Advance preparation and bedside availability of oxytocin before childbirth was significantly and rob...
Abstract Background Postpartum haemorrhage (PPH) is a major cause of maternal mortality and morbidit...
To compare maternal outcomes using Carbetocin versus Oxytocin for the active management of the third...
Abstract Background Primary postpartum haemorrhage (PPH) is one of the leading causes of maternal mo...
Background: Post-partum hemorrhage is the leading cause of maternal mortality worldwide. Use of uter...
BACKGROUND: Primary postpartum haemorrhage (PPH) is one of the leading causes of maternal morbidity ...
Background and Objectives: To determine and compare the effects of the timing of oxytocin administra...
Objective To compare the available evidence on intravenous oxytocin dosing regimens for the prevent...
BackgroundThere is no consensus on the best timing for prophylactic oxytocin administration during c...
Background: PPH is the prime cause of maternal mortality worldwide. The incidence of PPH can be dras...
Background: Administration of the uterotonic drugs is one of the main components of the active manag...
Postpartum hemorrhage is a leading cause of maternal death worldwide. Rapid provision of uterotonics...
Introduction Maternity care providers administer oxytocin prophylactically to prevent postpartum hem...
Postpartum hemorrhage is a leading cause of maternal death worldwide. Rapid provision of uterotonics...
Objective The aim of the study is to investigate whether carbetocin prevents postpartum hemorrhage (...
Advance preparation and bedside availability of oxytocin before childbirth was significantly and rob...
Abstract Background Postpartum haemorrhage (PPH) is a major cause of maternal mortality and morbidit...
To compare maternal outcomes using Carbetocin versus Oxytocin for the active management of the third...
Abstract Background Primary postpartum haemorrhage (PPH) is one of the leading causes of maternal mo...
Background: Post-partum hemorrhage is the leading cause of maternal mortality worldwide. Use of uter...
BACKGROUND: Primary postpartum haemorrhage (PPH) is one of the leading causes of maternal morbidity ...
Background and Objectives: To determine and compare the effects of the timing of oxytocin administra...
Objective To compare the available evidence on intravenous oxytocin dosing regimens for the prevent...